Publications by authors named "S Dimicoli"

Claim this Profile
E
Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.
Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa, Jean Pardo, Aspasia Stamatoullas, Sophie Dimicoli

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-NOR90 antibody associated with paraneoplastic systemic sclerosis.
Pierre Duffau, Sophie Dimicoli, Noemie Gensous, Marie-Elise Truchetet, Cecile Bordes

Clin Exp Rheumatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
Thibault Comont, Mathieu Meunier, Amina Cherait, Clemence Santana, Thomas Cluzeau, Sophie Dimicoli

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinblastine for elderly and frail patients with Hodgkin lymphoma.
Lucie Meynard, Jean Galtier, Simon Favre, Lucile Debus, Axelle Lascaux, Sophie Dimicoli

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.
Thomas Prebet, Jacques Delaunay, Eric Wattel, Thorsten Braun, Pascale Cony-Makhoul, Sophie Dimicoli

Br J Haematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis